Status:
COMPLETED
Health-related Quality of Life and Late Effects Among SURVivors of Cancer in Adolescence and Young Adulthood: The SURVAYA Study
Lead Sponsor:
The Netherlands Cancer Institute
Conditions:
Quality of Life
Late Effect
Eligibility:
All Genders
18-39 years
Brief Summary
Rationale: Adolescent and young adult (AYA) cancer survivors, diagnosed between 18-39 years, much more than children, suffer from delay in diagnosis, lack of centralization of care, age-adjusted exper...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pathological confirmed cancer diagnosis;
- Age 18 - 39 years at time of first cancer diagnosis;
- Provide written informed consent.
- Treated in an Academic hospital or Netherlands Cancer Institute
Exclusion
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT05379387
Start Date
May 1 2019
End Date
June 1 2021
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antoni van Leeuwenhoekziekenhuis
Amsterdam, Netherlands